Key Reasons to attend SMi's 3D Cell Culture Conference 2020
SMi Reports: Key sessions confirmed for SMi's 4th Annual 3D Cell Culture 2020 in London
By: SMi Group
Ahead of the conference, a variety of leading pharma companies have already been confirmed to attend such as MHRA, GSK, AstraZeneca, Merck, Sanofi Pasteur, Novartis and more.
For those interested in attending, there is an early bird offer with £200 savings for bookings made by 29th November, visit www.3D-cellculture.com/
Benefits of attending:
1) 18 engaging presentations from senior experts
2) 12+ hours of content in key industry developments, plus 5+ hours of networking
3) Panel discussion on adopting new technologies for 3d models
In addition to the agenda, a '3D Bioprinting' Focus Day will be held on 18th February 2020, led by prominent expert speakers. The focus day will explore case studies from big pharma, biotech's and academia exploring how bioprinting is being used, highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.
Key Sessions include:
Stefan Pryzborski, Professor Of Cell Technology, University Of Durham on 'The Development and Application of 3D Culture Techniques to Construct Models of Human
Philip Hewitt, UK & Eutrotox Registered Toxicologist, Head Of Early Investigative Technology, Merck on 'Organ-on-a-
Leonard Both, Senior Quality Assessor, Biologicals/
Medicines & Healthcare Products Regulatory Agency (MHRA) on 'Regulatory Outlook on 3D Cell Culture Models?'
The full agenda and speaker line-up are available in the download brochure online at www.3D-cellculture.com/
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or email@example.com
3D Cell Culture Conference 2020
Focus Day: 18 February 2020
Conference: 19th - 20th February 2020
Copthorne Tara Hotel, London, UK